SEARCH:   Advanced

Blood, Vol. 112, Issue 3, 741-749, August 1, 2008 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility Blood Ellis et al. 112: 741 Supplemental materials for: Ellis et al Files in this Data Supplement: Table S1. Interactive effect of MDM2 and TP53 genotypes on development of t-AML with prior radiotherapy (PDF, 11.2 KB) Table S2. Distributions of latencies stratified by cytogenetic abnormality (PDF, 9.89 KB) Table S3. Tests for associations between MDM2 or TP53 genotypes and t-AML with abnormality of chromosome 5 and/or 7 (PDF, 10.6 KB) Table S4. Relationships between de novo AML and MDM2 or TP53 genotypes in the United Kingdom case-control series (PDF, 10.7 KB) This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020